T-cell immune reconstitution after hematopoietic stem cell transplantation for HIV-associated lymphoma

Transplantation

Volumn 80, Issue 5, 2005, Pages 673-682

  Benicchi, Tiziana ^a   Ghidini, Claudia ^a   Re, Alessandro ^b   Cattaneo, Chiara ^b   Casari, Salvatore ^c   Caimi, Luigi ^c   Rossi, Giuseppe ^c   Imberti, Luisa ^a,d  

^a Department of Laboratory Diagnostics   (Italy)

^b UO Ematologia   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d Terzo Servizio Analisi   (Italy)

Author keywords

Hematopoietic stem cells; HIV associated lymphoma; T cell repertoire; TCR excision circles

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; DIDANOSINE; EFAVIRENZ; INDINAVIR; INTERLEUKIN 7; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; PREALBUMIN; RITONAVIR; STAVUDINE; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CELL DIVISION; GENETIC HETEROGENEITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; INTERFERON PRODUCTION; LYMPHOMA; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOVERY OF FUNCTION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VIREMIA;

EID: 25444515147     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000168490.29862.b8     Document Type: Article

References (40)

1. Levine AM. Acquired immunodeficiency syndrome-related lymphoma: clinical aspects. Semin Oncol 2000; 27: 442.
2. Kaplan LD, Straus DJ, Testa MA, et al. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 1997; 336: 1641.
3. Imberti L, Sottini A, Bettinardi A, et al. Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences. Science 1991; 254: 860.
4. Pantaleo G, Demarest JF, Soudeyns H, et al. Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature 1994; 370: 463.
5. Correa R, Muñoz-Fernández MA. Viral phenotype affects the thymical production of new T cells in HIV-1 infected children. AIDS 2001; 15: 1959.
6. + cell numbers and clinical staging. J Clin Invest 1989; 84: 1892.
7. Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328: 593.
8. Marks DI, Cullis JO, Ward KN, et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Intern Med 1993; 119: 207.
9. Small TN, Papadopoulos EB, Boulad F, et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 1999; 93: 467.
10. Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990; 5: 209.
11. Linch DC, Knott LJ, Thomas RM, et al. T cell regeneration after allogeneic and autologous bone marrow transplantation. Br J Haematol 1983; 53: 451.
12. Daley JP, Rozans MK, Smith BR, et al. Retarded recovery of functional T cell frequencies in T cell-depleted bone marrow transplant recipients. Blood 1987; 70: 960.
13. Roux E, Dumont-Girard F, Starobinski M, et al. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 2000; 96: 2299.
14. Guillaume T, Rubinstein DB, Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 1998; 92: 1471.
15. Bowden RA, Coombs RW, Nikora BH, et al. Progression of human immunodeficiency virus type-1 infection after allogeneic marrow transplantation. Am J Med 1990; 88: 49N.
16. Gabarre J, Leblond V, Sutton L, et al. Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma. Bone Marrow Transplant 1996; 18: 1195.
17. Re A, Cattaneo C, Michieli M, et al. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 2003; 21: 4423.
18. Krishnan A, Zaia J, Forman SJ. Should HIV-positive patients with lymphoma be offered stem cell transplants? Bone Marrow Transplant 2003; 32: 741.
19. Krishnan A, Molina A, Zaia J, et al. Durable remissions with autologous stem cell transplantation for high risk HIV-associated lymphomas. Blood 2005; 105: 874.
20. + hematopoietic progenitors. Blood 1998; 91: 2588.
21. Gorski J, Yassai M, Zhu X, et al. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. J Immunol 1994; 152: 5109.
22. Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995; 16: 176.
23. Zhang L, Lewin SR, Markowitz M, et al. Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J Exp Med 1999; 190: 725.
24. Sottini A, Quiros-Roldan E, Albertini A, et al. Assessment of T-cell receptor beta-chain diversity by heteroduplex analysis. Hum Immunol 1996; 48: 12.
25. Jeddi-Tehrani M, Grunewald J, Hodara V, et al. Nonrandom T-cell receptor J beta usage pattern in human CD4+ and CD8+ peripheral T cells. Hum Immunol 1994; 40: 93.
26. Hingorani R, Choi IH, Akolkar P, et al. Clonal predominance of T cell receptors within the CD8+ CD45RO+ subset in normal human subjects. J Immunol 1993; 151: 5762.
27. Peggs KS, Verfuerth S, D'Sa S, et al. Assessing diversity: immune reconstitution and T-cell receptor BV spectratype analysis following stem cell transplantation. Br J Haematol 2003; 120: 154.
28. + T lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332: 143.
29. + T cells and T cell activation markers in HIV-1 infected children on HAART. Clin Exp Immunol 2001; 125: 266.
30. Bonyhadi ML, Rabin L, Salimi S, et al. HIV induces thymus depletion in vivo. Nature 1993; 363: 728.
31. Haynes BF, Markert ML, Sempowski GD, et al. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu Rev Immunol 2000; 18: 529.
32. Napolitano LA, Grant RM, Deeks SG, et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001; 7: 73.
33. Okamoto Y, Douek DC, McFarland RD, et al. Effects of exogenous interleukin-7 on human thymus function. Blood 2002; 99: 2851.
34. Van den Brink MR, Alpdogan O, Boyd RL. Strategies to enhance T-cell reconstitution in immunocompromised patients. Nat Rev Immunol 2004; 4: 856.
35. Douek DC, Vescio RA, Betts MR, et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 2000; 355: 1875.
36. +) T-helper cells after human allogeneic bone marrow transplantation. Blood 1997; 90: 850.
37. Mackall CL, Bare CV, Granger LA, et al. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 1996; 156: 4609.
38. Storek J, Witherspoon RP, Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 1995; 16: 413.
39. Mitra DK, Singh HP, Singh M, et al. Reconstitution of naive T cells and type 1 function after autologous peripheral stem cell transplantation: impact on the relapse of original cancer. Transplantation 2002; 73: 1336.
40. Guo H, Qiao Z, Zhu L, et al. Th1/Th2 cytokine profiles and their relationship to clinical features in patients following nonmyeloablative allogeneic stem cell transplantation. Am J Hematol 2004; 75: 78.